JPM | Free Full-Text | Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
The value of rituximab treatment in primary Sjögren's syndrome - ScienceDirect
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rituximab-related Severe Toxicity | SpringerLink
PV | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience | Annals of the Rheumatic Diseases
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar | Immunotherapy
Rituximab - Wikipedia
Internet Scientific Publications
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Targeting CD20: Monoclonals of the future - ppt download
Rituximab for the treatment of multiple sclerosis: a review | SpringerLink
Rituximab in neurological disease: principles, evidence and practice | Practical Neurology
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Rituximab mode of action: apoptosis and ADCC. Rituximab mediated... | Download Scientific Diagram
Rituximab - Wikipedia
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
